 | | | | When Alexei Voronenkov's 70-year-old mother passed away, he paid to have her brain frozen and stored in the hope breakthroughs in science will one day be able to bring her back to life. | | |
| | | There may have been limited human-to-human transmission of a new coronavirus in China within families, and it is possible there could be a wider outbreak, the World Health Organization (WHO) said on Tuesday. | | |
| | | Biotechnology giant Amgen Inc expects up to a quarter of its growth to come from Asia over the next decade, Chief Executive Officer Robert Bradway told Reuters. | | |
| | | Swiss drugmaker Roche plans to price its oral spinal muscular atrophy drug (SMA) risdiplam aggressively to challenge two of the world's most expensive medicines, Biogen's Spinraza and Novartis's gene therapy Zolgensma. | | |
| | | (Reuters Health) - For each patient they see, doctors spend about 16 minutes using electronic health records, a U.S. study finds. | | |
| | | (Reuters Health) - Black and Latino patients treated for kidney stones in emergency departments around the U.S. tend to get less pain-killing medication compared to whites, a new study finds. | | |
| | | (Reuters Health) - Coaches who teach young male athletes about respectful relationship behaviors may be able to help prevent dating violence and aggressive behavior toward female peers, a U.S. study suggests. | | |
| | | Novartis and Britain's National Health Service (NHS) on Monday announced a pact that will clear the way for accelerated review by the country's health watchdog NICE for heart drug inclisiran, which could make it broadly available as soon as 2021. | | |
| | | (Reuters Health) - Drowning death rates are three to four times lower in states that regulate swimming in oceans, rivers and lakes, a U.S. study suggests. | | |
| | | A new outbreak of bird flu was reported in Poland on Monday, with around 6,000 geese now set to be exterminated, a regional spokesman confirmed to Reuters, adding to about half a dozen cases already detected across the country since December. | | |
| | | Biogen Inc said on Monday it has agreed to buy an early-stage experimental treatment from Pfizer Inc that it aims to test in patients with Alzheimer's and Parkinson's disease. | | |
|
| |
